ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 2 filers reported holding ALBIREO PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $613,000 | -8.1% | 20,553 | -28.2% | 0.00% | 0.0% |
Q4 2021 | $667,000 | -25.7% | 28,623 | -0.6% | 0.00% | -50.0% |
Q3 2021 | $898,000 | -12.4% | 28,790 | -1.2% | 0.00% | -20.0% |
Q2 2021 | $1,025,000 | +3.7% | 29,125 | +3.9% | 0.01% | +25.0% |
Q1 2021 | $988,000 | -32.7% | 28,035 | -28.4% | 0.00% | -33.3% |
Q4 2020 | $1,469,000 | +110.8% | 39,165 | +87.5% | 0.01% | +100.0% |
Q3 2020 | $697,000 | +100.9% | 20,890 | +59.3% | 0.00% | +50.0% |
Q2 2020 | $347,000 | – | 13,110 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 270,146 | $6,627,000 | 3.42% |
Perceptive Advisors | 1,704,330 | $39,506,000 | 1.50% |
Birchview Capital, LP | 38,000 | $932,000 | 0.88% |
SECTORAL ASSET MANAGEMENT INC | 229,978 | $5,641,000 | 0.77% |
BVF INC/IL | 200,500 | $4,918,000 | 0.64% |
Artal Group S.A. | 500,000 | $12,265,000 | 0.45% |
PA Capital LLC | 14,692 | $360,000 | 0.38% |
Chicago Capital, LLC | 180,911 | $4,438,000 | 0.36% |
TPG Group Holdings (SBS) Advisors, Inc. | 716,381 | $17,573,000 | 0.28% |
Fosun International Ltd | 197,005 | $4,492,000 | 0.27% |